Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
PARD6B |
par-6 family cell polarity regulator beta |
20q13.13 |
rSNP target |
0
|
TAS
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IDA[12130699]
|
RBM38 |
RNA binding motif protein 38 |
20q13.31 |
rSNP target |
0
|
IDA[17050675]; IEA
|
STMN1 |
stathmin 1 |
1p36.11 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(1/5/0)
|
IEA
|
PFKFB3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
10p15.1 |
rSNP target |
0
|
TAS
|
RAB5A |
RAB5A, member RAS oncogene family |
3p24.3 |
rSNP target |
0
|
IDA[23382462]
|
APOA1 |
apolipoprotein A-I |
11q23-q24 |
Mapped by LD-proxy |
0
|
TAS
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
IEA
|
DIAPH3 |
diaphanous related formin 3 |
13q21.2 |
Literature-origin |
1(0/0/1)
|
TAS
|
RPS29 |
ribosomal protein S29 |
14q21.3 |
Literature-origin |
1(0/0/1)
|
TAS
|
NANS |
N-acetylneuraminate synthase |
9p24.1-p23 |
rSNP target |
0
|
TAS
|
PRKCA |
protein kinase C, alpha |
17q24.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
10(9/0/1)
|
IDA[17983652]; TAS
|
RPL10A |
ribosomal protein L10a |
6p21.31 |
rSNP target |
0
|
TAS
|
PSMA4 |
proteasome subunit alpha 4 |
15q24.1 |
Mapped by LD-proxy, rSNP target |
0
|
TAS
|
TH |
tyrosine hydroxylase |
11p15.5 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
TAS
|
CAST |
calpastatin |
5q15 |
rSNP target |
0
|
IDA[14559243]
|
WWC1 |
WW and C2 domain containing 1 |
5q34 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
6(6/0/0)
|
IDA[24682284]; TAS
|
CAT |
catalase |
11p13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|
ARRB1 |
arrestin, beta 1 |
11q13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
TAS
|
NOS1AP |
nitric oxide synthase 1 adaptor protein |
1q23.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(3/0/0)
|
ISS[24665357]
|
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
6q25.1 |
rSNP target |
0
|
TAS
|
TPH1 |
tryptophan hydroxylase 1 |
11p15.3-p14 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
5(1/4/0)
|
TAS
|
ASL |
argininosuccinate lyase |
7q11.21 |
rSNP target |
0
|
IBA; TAS
|
PRTFDC1 |
phosphoribosyl transferase domain containing 1 |
10p12.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
IBA
|
KPNA3 |
karyopherin alpha 3 |
13q14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
IBA; TAS
|
NUCB2 |
nucleobindin 2 |
11p15.1 |
rSNP target |
0
|
TAS[7811391]
|
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(2/4/0)
|
IEA
|
CAV3 |
caveolin 3 |
3p25 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IEA
|
OXTR |
oxytocin receptor |
3p25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
IEA
|
ACTC1 |
actin, alpha, cardiac muscle 1 |
15q14 |
rSNP target |
0
|
TAS
|
INMT |
indolethylamine N-methyltransferase |
7p14.3 |
rSNP target |
0
|
IDA[10552930]
|
RARS |
arginyl-tRNA synthetase |
5q35.1 |
rSNP target |
0
|
TAS
|
TPH2 |
tryptophan hydroxylase 2 |
12q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
10(3/7/0)
|
TAS
|
PTK2B |
protein tyrosine kinase 2 beta |
8p21.1 |
Mapped by LD-proxy |
0
|
TAS
|
JAK1 |
Janus kinase 1 |
1p32.3-p31.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
KIF18A |
kinesin family member 18A |
11p14.1 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
TAS
|
IL1A |
interleukin 1 alpha |
2q14 |
rSNP target |
0
|
IDA[12746488]
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(9/12/0)
|
TAS
|
IL1B |
interleukin 1 beta |
2q14 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
TAS
|
CAPRIN1 |
cell cycle associated protein 1 |
11p13 |
rSNP target |
0
|
IEA
|
UAP1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 |
1q23.2 |
rSNP target |
0
|
IBA; TAS
|
APOA1BP |
apolipoprotein A-I binding protein |
1q21 |
rSNP target |
0
|
IEA
|
OPRL1 |
opiate receptor-like 1 |
20q13.33 |
Literature-origin, Mapped by Literature SNP |
0
|
IGI[10571060]
|
PIK3C2A |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
11p15.5-p14 |
rSNP target |
0
|
TAS
|
DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
IBA; IDA[1331329]; IEA
|
MOB1A |
MOB kinase activator 1A |
2p13.1 |
rSNP target |
0
|
TAS
|
IMPDH1 |
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
7q31.3-q32 |
rSNP target |
0
|
TAS
|
CLTC |
clathrin heavy chain |
17q23.1 |
rSNP target |
0
|
TAS
|
NOS1 |
nitric oxide synthase 1 |
12q24.22 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
TAS
|
RGS7 |
regulator of G-protein signaling 7 |
1q43 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IDA[10521509]
|
TULP1 |
tubby like protein 1 |
6p21.3 |
Mapped by LD-proxy |
0
|
IEA
|
CDK1 |
cyclin-dependent kinase 1 |
10q21.2 |
rSNP target |
0
|
TAS
|
APOB |
apolipoprotein B |
2p24-p23 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
TAS
|
BLMH |
bleomycin hydrolase |
17q11.2 |
Mapped by LD-proxy |
0
|
TAS
|
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
TAS
|
TRIM37 |
tripartite motif containing 37 |
17q22 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
IDA[11279055]
|
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
1q32.1 |
rSNP target |
0
|
IDA[10940933]
|
NOD1 |
nucleotide binding oligomerization domain containing 1 |
7p14.3 |
rSNP target |
0
|
TAS
|
PRKG1 |
protein kinase, cGMP-dependent, type I |
10q11.2 |
Literature-origin, Mapped by Literature SNP |
1(0/0/1)
|
TAS
|
TRAF7 |
TNF receptor associated factor 7 |
16p13.3 |
rSNP target |
0
|
IEA
|
VASP |
vasodilator-stimulated phosphoprotein |
19q13.32 |
Mapped by Literature SNP |
0
|
TAS
|
SMG8 |
SMG8 nonsense mediated mRNA decay factor |
17q23.2 |
rSNP target |
0
|
TAS
|
RAD21 |
RAD21 cohesin complex component |
8q24.11 |
rSNP target |
0
|
TAS
|
MAPT |
microtubule associated protein tau |
17q21 |
Mapped by LD-proxy, rSNP target |
0
|
TAS
|
EPHX2 |
epoxide hydrolase 2 |
8p21 |
Mapped by LD-proxy, rSNP target |
0
|
IDA[8342951|16314446|18513744]; NAS[10862610]; TAS
|
RGS2 |
regulator of G-protein signaling 2 |
1q31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
7(2/5/0)
|
ISS
|
GGCT |
gamma-glutamylcyclotransferase |
7p15-p14 |
rSNP target |
0
|
IDA[16765912]; TAS
|
KAT2B |
K(lysine) acetyltransferase 2B |
3p24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IEA
|
TP53 |
tumor protein p53 |
17p13.1 |
rSNP target |
0
|
IDA[14963330|24101517]
|
DTNBP1 |
dystrobrevin binding protein 1 |
6p22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
5(2/3/0)
|
TAS
|
SKA2 |
spindle and kinetochore associated complex subunit 2 |
17q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
2(0/2/0)
|
TAS
|
GARS |
glycyl-tRNA synthetase |
7p15 |
Mapped by LD-proxy, rSNP target |
0
|
TAS
|
NDRG1 |
N-myc downstream regulated 1 |
8q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IEA
|
UCHL5 |
ubiquitin C-terminal hydrolase L5 |
1q32 |
rSNP target |
0
|
IDA[18922472]
|
ADCYAP1 |
adenylate cyclase activating polypeptide 1 (pituitary) |
18p11 |
Literature-origin |
6(0/6/0)
|
IEA
|
DCTN1 |
dynactin subunit 1 |
2p13 |
rSNP target |
0
|
TAS
|
ARHGAP26 |
Rho GTPase activating protein 26 |
5q31 |
rSNP target |
0
|
TAS
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
44(13/31/0)
|
IDA[19270731]
|